Company Search:
Advanced Search
Sponsored Links
Nibec Company Snapshot
Nibec operates in the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Nibec with three other pharmaceutical manufacturers in Asia: AnyGen Co Ltd (2016 sales of 4.18 billion Korean Won [US$3.94 million] ), Phong Phu Pharmaceutical JSC of Vietnam (120.90 billion Dong [US$5.32 million] ), and Gujarat Themis Biosyn Limited which is based in India (326.25 million Indian Rupees [US$5.13 million] ).

Sales Analysis. Nibec reported sales of 4.80 billion Korean Won (US$4.53 million) for the year ending December of 2016. This represents an increase of 15.1% versus 2015, when the company's sales were 4.17 billion Korean Won.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
  Stock Performance Chart for Nibec
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 11,700
(Figures in Korean Won)
1 Week 4.5%   13 Weeks 9.3%  
4 Weeks 46.6%   52 Weeks 34.0%  
Nibec Key Data:
  Ticker: 138610 Country: Korea (South)
  Exchanges: SEO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2016 Sales 4,804,231,773
(Year Ending Jan 2017).
Employees: 31
  Currency: Korean Won Market Cap: 63,879,636,600
  Fiscal Yr Ends: December Shares Outstanding: 5,459,798
  Share Type: Common Closely Held Shares: 1,445,065
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.